Oxford Biomedica PLC
17 May 2007
BLOCKLISTING SIX MONTHLY RETURN
1. Name of company OXFORD BIOMEDICA PLC
2. Name of scheme SHARE OPTION SCHEME
3. Period of return: From : 18 November 2006 To : 17 May 2007
4. Number and class of share(s) (amount of stock / debt security) not issued
under scheme:
6,162,013 ORDINARY SHARES OF 1P EACH
5. Number of shares issued / allotted under scheme during period:
1,200,827 ORDINARY SHARES OF 1P EACH
6. Balance under scheme not yet issued / allotted at end of period:
4,961,186 ORDINARY SHARES OF 1P EACH
7. Number and class of share(s) (amount of stock / debt securities) originally
listed and the date of admission:
17,383,143 ORDINARY SHARES OF 1P EACH: DATE ADMITTED 9 May 2001
Please confirm total number of shares in issue at the end of the period in order
for us to update our records:
533,939,015 ORDINARY SHARES OF 1P EACH
Contact for queries
Name ANDREW WOOD
Address OXFORD BIOMEDICA PLC, MEDAWAR CENTRE,
OXFORD SCIENCE PARK, OXFORD OX4 4GA
Telephone 01865 783000
Person making the return
Name ANDREW WOOD
Position COMPANY SECRETARY
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.